Elevated levels of IFN-γ and STAT1 signaling are implicated in chronic lymphoid-driven human diseases, such as SLE36, 39, 42 and in mouse models of SLE, including the MRL/lpr strain39, 40. This evidence concerns the gene STAT1 and glycogen storage disease VI.